The escalating burden of vector-borne diseases (VBDs) in India necessitates a comprehensive understanding and approach among healthcare professionals. This review aims to provide a detailed overview of the current situation, challenges, and potential solutions.
India, with its diverse ecology, is a hotspot for VBDs, including malaria, dengue, and chikungunya. According to the World Health Organization, India accounts for 89% of South-East Asia's malaria burden. Dengue cases have also seen a dramatic rise, with over 100,000 cases reported in 2019. The geographical spread and intensity of these diseases have increased significantly, posing a significant public health challenge.
The major challenges include inadequate surveillance, vector control measures, and public awareness. Additionally, climate change and urbanization contribute to the proliferation of vectors, further complicating the situation. The lack of a robust healthcare infrastructure, particularly in rural areas, also hampers effective disease control.
Addressing VBDs requires a multi-pronged approach. Strengthening surveillance systems and improving diagnostic capacities are critical. Investing in research and development for new tools, including vaccines and vector control methods, is necessary. Public health education campaigns can significantly enhance community participation in vector control efforts. Furthermore, inter-sectoral collaboration involving the health, environment, and urban planning sectors is crucial for a comprehensive response.
Healthcare professionals play a pivotal role in managing VBDs. They are at the forefront of early detection, management, and reporting of cases. Their active participation in public health education can significantly improve community awareness and engagement.
Addressing the rising threat of VBDs in India requires concerted efforts from all stakeholders, including healthcare professionals. By enhancing their understanding and capabilities, we can significantly improve the management of these diseases and mitigate their public health impact.
1.
Researchers use genomic technology to investigate aggressive skin cancer linked to burn scars
2.
The Growing Role of AI in Cancer Treatment
3.
Tafasitamab Regimen Improves PFS in Relapsed/Refractory Follicular Lymphoma
4.
Lower Prostate Cancer Mortality Linked to Unavailable Clinical Trials.
5.
Powerlifting through breast cancer: How a breast cancer survivor defied chemotherapy with strength training
1.
Drug Exposure in Tumor Microenvironments: Mechanisms, Clinical Implications, and Emerging Strategies
2.
Proteoform Networks in Blood Disorders: Mechanisms, Clinical Implications, and Emerging Therapeutic Strategies
3.
Antibody-Drug Conjugates and the Dawn of Targeted Cancer Therapy in 2025
4.
Revolutionizing Oncology Trials: Optimization, Matching, Diversity, and Decentralization
5.
Direct Oral Anticoagulants (DOACs) in Atrial Fibrillation: A Comprehensive Review
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
An Eagles View - Evidence-based Discussion on Iron Deficiency Anemia- Panel Discussion- Part II
2.
Expert Group meeting with the management of EGFR mutation positive NSCLC - Part IV
3.
Targeting Oncologic Drivers with Dacomitinib: A New Approach to Lung Cancer Treatment
4.
How Multidisciplinary Teams Support Modern Cancer Care
5.
Influence of CDK4/6 Inhibitors in Extending Progression-Free Survival (PFS) and Overall Survival in HR+/HER2- mBC Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation